IFIH1 and lymphopenia: Multiple previous studies have reported that peripheral blood lymphocytopenia is one of the characteristic clinical manifestations of anti-MDA5 + DM [9], and peripheral blood lymphocyte count can assist in judging the prognosis of patients [10].